Hematologic Safety Profile of Linezolid in the Early Periengraftment Period after Allogeneic Stem Cell Transplantation
Open Access
- 31 October 2009
- journal article
- clinical trial
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 15 (10), 1337-1341
- https://doi.org/10.1016/j.bbmt.2009.05.021
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Colonization, Bloodstream Infection, and Mortality Caused by Vancomycin-Resistant Enterococcus Early after Allogeneic Hematopoietic Stem Cell TransplantTransplantation and Cellular Therapy, 2007
- Efficacy and Safety of Linezolid Compared with Vancomycin in a Randomized, Double-Blind Study of Febrile Neutropenic Patients with CancerClinical Infectious Diseases, 2006
- Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipientsTransplant Infectious Disease, 2005
- Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical courseBone Marrow Transplantation, 2005
- Similar Hematologic Effects of Long‐Term Linezolid and Vancomycin Therapy in a Prospective Observational Study of Patients with Orthopedic InfectionsClinical Infectious Diseases, 2004
- Linezolid Does Not Increase the Risk of Thrombocytopenia in Patients with Nosocomial Pneumonia: Comparative Analysis of Linezolid and Vancomycin UseClinical Infectious Diseases, 2003
- Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III StudiesAntimicrobial Agents and Chemotherapy, 2003
- Thrombocytopenia Associated with Linezolid TherapyClinical Infectious Diseases, 2002
- Linezolid-Induced Anemia and ThrombocytopeniaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- Hematologic Effects of Antimicrobials: Focus on the Oxazolidinone LinezolidPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001